Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

Brand differentiation is key in order for Boohoo to harness Misspap as its next vehicle for growth

Following yesterday’s news (Monday 25 March) that the Boohoo group has acquired Misspap, Sofie Willmott, Senior Retail Analyst at GlobalData, a leading data and analytics company, offers her view on the chains current challenges: “The Boohoo group’s acquisition of Misspap will give the retailer another vehicle to drive rapid growth, as it has done with PrettyLittleThing, […]
Read more
,

Apple TV’s fortunes will depend on content and user experience, neither of which look rosy

Following Apple’s announcement yesterday (Monday 25 March) of its Apple TV+ streaming service, Cyrus Mewawalla, Head of Thematic Research at GlobalData, has warned the company’s journey towards internet TV services faces a bumpy ride: “Apple’s move marks a major shift in the company’s focus from hardware to services. But video streaming is a market where […]
Read more
,

Trinidad’s revenue-raising measures risk backfiring in long-term

Trinidad and Tobago is looking to attract exploration investment with a new offshore bid round. However, the introduction of a royalty imposed on investors may be counter-productive for the government in the longer term, according to GlobalData, a leading data and analytics company. Toya Latham, Oil and Gas Analyst for GlobalData commented: “The imposition of a 12.5% royalty, […]
Read more

Administration looms as Debenhams reveals restructuring plans

Following the announcement of Debenhams new restructuring plans, Patrick O’Brien, UK Retail Research Director at GlobalData, a leading data and analytics company, offers his view: “Mike Ashley’s attempt to create a ‘House of Debenhams’ looks doomed to be an expensive failure after Debenhams revealed its restructuring plans. It looks likely that creditors will approve plans […]
Read more

Sleep boosting DNA repair in damaged neurons could significantly impact the treatment of mental illnesses

A recent study conducted at Bar-Ilan University in Israel found that DNA repair in damaged neurons is most efficient during sleep, and treating sleep disorders is a vastly growing area of innovation in the pharmaceutical industry. Magdalene Crabbe, Neurology and Ophthalmology Analyst at GlobalData, a leading data and analytics company, discusses the revelation: “Considering the […]
Read more

Stationery specialist Office Outlet left behind as the market steams ahead

Commenting on the news that Office Outlet has collapsed into administration, Zoe Mills, UK Retail Analyst at GlobalData, offers her view: “The stationery market is booming, forecast to grow 3.6% in 2019 and far outpacing UK non-food growth. However, following Paperchase’s CVA announcement earlier this month, yet another stationery retailer is in trouble. “Growth in […]
Read more

$43bn FIS and Worldpay merger creates new processing giant

Following the news of the merger agreement between Fidelity Information Services (FIS) and Worldpay, Bhavika Shah, Payments Analyst at GlobalData, a leading data and analytics company offers her view: “With the acquisition of Worldpay, FIS stands to drastically improve its position in the US market by combining the two companies’ complementary services. “In 2018, Worldpay processed […]
Read more

M&S faces uphill battle to win over weekly food shoppers

Following the news that M&S are planning to expand the number of stores offering the full range of M&S food products, Thomas Brereton, Retail Analyst for GlobalData, a leading data and analytics company, offers his view: “It is understandable that M&S Food’s Managing Director Stuart Machin is looking to expand the food side of the business; over the […]
Read more

Not just Arcadia: Fashion is fleeing the high street

Following today’s news (Friday 15 March) that Arcadia is reportedly poised to launch a CVA, Sofie Willmott, Senior Retail Analyst at GlobalData, a leading data and analytics company, offers her view on the chains current challenges: “News that Arcadia is poised to launch a CVA comes as no surprise as clothing & footwear spend continues […]
Read more

Tecentriq assumes pole position with FDA approval but Keytruda looms in triple negative breast cancer

On March 8, the FDA granted the accelerated approval of Roche’s programmed cell death protein 1 (PD-1) inhibitor Tecentriq in combination with Abraxane (protein-bound paclitaxel) for the treatment of locally advanced or metastatic triple-negative breast cancer (TNBC). Adam Pearson, PhD, Oncology and Hematology Analyst at GlobalData, a leading data and analytics company, offers his view […]
Read more

Mild February fails to significantly boost UK retail spending

February proved to be another disheartening month for retailers as the total retail spend index rose only 3.4 percentage points (ppts) versus a poor performance in January, according to GlobalData, a leading data and analytics company. This subdued growth is especially disappointing in light of the UK experiencing the hottest February on record, which should have […]
Read more
1 … 84 85 86 87 88 … 93